99% Invisible cover image

Orphan Drugs

99% Invisible

00:00

Lev Pharmaceuticals' Unusual Path to Market

Dan recounts Joshua Schein merging with a popcorn company to become publicly traded and fund trials for a rare-disease drug.

Play episode from 16:40
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app